CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TRDA — Entrada Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,450,920
-$1,259,237 QoQ
Shares Held
197,136
-8.2% QoQ
Ownership
0.506%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. TRDA ranks #205 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,450,920 | 197,136 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,710,157 | 214,751 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,274,645 | 221,269 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,074,502 | 185,259 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,368,816 | 203,693 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,742,161 | 192,717 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,408,325 | 197,127 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,972,024 | 185,984 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,313,359 | 162,341 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,219,432 | 156,629 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,283,992 | 151,358 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,452,539 | 155,224 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,156,193 | 142,417 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,297,431 | 89,478 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,202,874 | 88,970 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,384,657 | 87,859 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $521,084 | 42,782 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $645,130 | 68,704 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,096,005 | 64,019 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||